These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33997815)

  • 1. Phenotypic analysis of a transgenic
    Sekiya M; Iijima KM
    STAR Protoc; 2021 Jun; 2(2):100501. PubMed ID: 33997815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease.
    Bergkvist L; Du Z; Elovsson G; Appelqvist H; Itzhaki LS; Kumita JR; Kågedal K; Brorsson AC
    FEBS Open Bio; 2020 Mar; 10(3):338-350. PubMed ID: 31823504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic Drosophila models of Alzheimer's disease and tauopathies.
    Iijima-Ando K; Iijima K
    Brain Struct Funct; 2010 Mar; 214(2-3):245-62. PubMed ID: 19967412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Dissection of Alzheimer's Disease Using
    Jeon Y; Lee JH; Choi B; Won SY; Cho KS
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Aβ Proteotoxicity and Therapeutic Candidates Using
    Elovsson G; Bergkvist L; Brorsson AC
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease.
    Iijima K; Liu HP; Chiang AS; Hearn SA; Konsolaki M; Zhong Y
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6623-8. PubMed ID: 15069204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of transgenic Drosophila model of Alzheimer disease].
    Tan Y; Ji YB; Zhao J
    Yao Xue Xue Bao; 2013 Mar; 48(3):333-6. PubMed ID: 23724643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid fibril polymorphism and cell-specific toxicity
    Jonson M; Nyström S; Sandberg A; Carlback M; Michno W; Hanrieder J; Starkenberg A; Peter K; Nilsson R; Thor S; Hammarström P
    Amyloid; 2019; 26(sup1):136-137. PubMed ID: 31343327
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression in drosophila of tandem amyloid β peptides provides insights into links between aggregation and neurotoxicity.
    Speretta E; Jahn TR; Tartaglia GG; Favrin G; Barros TP; Imarisio S; Lomas DA; Luheshi LM; Crowther DC; Dobson CM
    J Biol Chem; 2012 Jun; 287(24):20748-54. PubMed ID: 22461632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drosophila melanogaster as a Model for Studies on the Early Stages of Alzheimer's Disease.
    Lim JY; Ott S; Crowther DC
    Methods Mol Biol; 2016; 1303():227-39. PubMed ID: 26235070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel genes that modify phenotypes induced by Alzheimer's beta-amyloid overexpression in Drosophila.
    Cao W; Song HJ; Gangi T; Kelkar A; Antani I; Garza D; Konsolaki M
    Genetics; 2008 Mar; 178(3):1457-71. PubMed ID: 18245849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila Eye Model to Study Neuroprotective Role of CREB Binding Protein (CBP) in Alzheimer's Disease.
    Cutler T; Sarkar A; Moran M; Steffensmeier A; Puli OR; Mancini G; Tare M; Gogia N; Singh A
    PLoS One; 2015; 10(9):e0137691. PubMed ID: 26367392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster.
    Sandin L; Bergkvist L; Nath S; Kielkopf C; Janefjord C; Helmfors L; Zetterberg H; Blennow K; Li H; Nilsberth C; Garner B; Brorsson AC; Kågedal K
    FEBS J; 2016 Oct; 283(19):3508-3522. PubMed ID: 27562772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using
    O'Keefe L; Denton D
    Biomed Res Int; 2018; 2018():5195416. PubMed ID: 29888266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miro, a Rho GTPase genetically interacts with Alzheimer's disease-associated genes (
    Panchal K; Tiwari AK
    Biol Open; 2020 Sep; 9(9):. PubMed ID: 32747449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targets from a Drosophila model of Alzheimer's disease.
    Crowther DC; Kinghorn KJ; Page R; Lomas DA
    Curr Opin Pharmacol; 2004 Oct; 4(5):513-6. PubMed ID: 15351357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid peptides and ion channel function in Drosophila models of Alzheimer's disease.
    Brown LA; Mee CJ; Kidd JF; Sattelle DB
    SEB Exp Biol Ser; 2008; 60():79-92. PubMed ID: 18309788
    [No Abstract]   [Full Text] [Related]  

  • 19. Invertebrate models of Alzheimer's disease.
    Link CD
    Genes Brain Behav; 2005 Apr; 4(3):147-56. PubMed ID: 15810903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Aβ toxicity mechanisms in a Drosophila model.
    Ott S; Dziadulewicz N; Crowther DC
    Dis Model Mech; 2015 Jul; 8(7):657-67. PubMed ID: 26035384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.